Skin Cancer

Patient adherence to self-management strategies can be difficult.

Catch up on the innovative pearls shared at the 2023 American College of Mohs Surgery including strategies to enhace the patient experience, the role artificial intelligence plays in dermatologic care, and more.

In a large cohort of transgender patients, gender-affirming hormone therapy did not have an effect on the incidence of skin cancers.

In part 1 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.

Brandon Beal, MD shared his experience, which technology solutions work best, and resources available to dermatology practices.

The rapid pearl session explored a case that challenged surgeons to preserve the function of the tarsal plate and musculature attachments.

Nicole Vélez, MD, provided marketing pearls to streamline mundane tasks and promote your practice in the digital world.

His keynote speech at ACMS focused on artificial intelligence for precision medicine and cancer diagnosis.

Jerry Brewer, MD, MS, shared pearls on reasons to avoid or discontinue Mohs surgery and keeping calm with stressed, vulnerable patients.

Katie Schlenker, DO, emphasizes the importance of empathy during tough conversations with skin cancer patients with few to no treatment options left.

Collins said an office environment impacts outcomes and shared office design considerations.

One ACMS session focused on creating a memorable experience for patients with office space, online presence, and practice management to attract and retain great patients and staff.

Golda explains why he prefers using tranexamic acid to control bleeding in granulated wounds.

An ACMS poster session indicates Mohs micrographic surgeons and histology technicians are at high risk of developing musculoskeletal injuries from their day-to-day tasks.

Laura Rezac, MD and her colleagues evaluated a teledermatology postoperative follow-up model after Mohs Micrographic surgery.

Caleb Kovell, MD and Junqian Zhang, MD demonstrated how teaming up increases the likelihood for positive patient outcomes in Mohs cases on the genitalia and perianal region.

The question was a conversation starter after an ACMS clinical abstract presentation.

An ACMS poster session delves into the role artificial intelligence can play in the treatment of basal cell carcinoma.

A poster session and ACMS keynote speaker Anant Madabhushi, MS, PhD, both delve into the use of AI in Mohs surgery.

Bar will share insight on foldover interpolated flaps for full thickness of nasal defects.

The ACMS president and scientific program chair share opportunities to discover innovations in Mohs surgery during this weekend’s meeting.

May is National Skin Cancer and Melanoma Awareness Month. We have skin cancer at the forefront of our coverage this month. Here is a recap of the latest news about skin cancer research, studies, and more.

Using mass spectrometry, researchers examined novel changes to gather updated metastasis information.

The results of a new study reveal that the the antibody works by activating the immune response to fight cancer and slows melanoma growth in mice.

From explaining how medications work and should be taken to reviewing potential adverse effects and financial details, pharmacists are crucial resources for patients undergoing treatment for skin cancer.

Researchers identified several dermoscopic features associated with genes LINC00518, PRAME, and TERT.

Researchers said responses may depend on prior immunotherapy.

Data from the KEYNOTE-942 trial was presented at the American Association for Cancer Research Annual Meeting 2023.

Merck and Eisai discontinued the trial based on recommendations of an independent data monitoring committee.

The PD-1 inhibitor pembrolizumab has proven its efficacy in a number of different cancers.